Company Search:
Advanced Search
Sponsored Links
Livzon Pharmaceutical Group Incorporated Company Snapshot
Livzon Pharmaceutical Group Incorporated operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Livzon Pharmaceutical Group Incorporated with three other companies in this sector in China: Chongqing Taiji Industry (Group) (2015 sales of 7.16 billion Chinese Renmimbi [US$1.04 billion] of which 56% was Trading), Huapont-Nutrichem Co Ltd (6.17 billion Chinese Renmimbi [US$896.20 million] of which 67% was Agricultural Business), and Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (7.08 billion Chinese Renmimbi [US$1.03 billion] of which 62% was Chinese Medicine).

Sales Analysis. During the year ended December of 2015, sales at Livzon Pharmaceutical Group Incorporated were 6.62 billion Chinese Renmimbi (US$961.89 million). This is an increase of 19.4% versus 2014, when the company's sales were 5.54 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Livzon Pharmaceutical Group Incorporated (and since 2010, sales have increased a total of 143%). Sales of Materials saw an increase of 33.1% in 2015, from 1.14 billion Chinese Renmimbi to 1.52 billion Chinese Renmimbi. Not all segments of Livzon Pharmaceutical Group Incorporated experienced an increase in sales in 2015: sales of Other fell 49.2% to 5.69 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Livzon Pharmaceutical Group Incorporated
  Stock Performance Chart for Livzon Pharmaceutical Group Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 56.25
(Figures in Chinese Renmimbi)
1 Week 3.4%   13 Weeks -2.3%  
4 Weeks -1.1%   52 Weeks 27.6%  
Livzon Pharmaceutical Group Incorporated Key Data:
  Ticker: 000513 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 6,620,516,537
(Year Ending Jan 2016).
Employees: 5,913
  Currency: Chinese Renmimbi Market Cap: 23,947,319,588
  Fiscal Yr Ends: December Shares Outstanding: 425,730,126
  Share Type: A Gu Closely Held Shares: 201,525,992
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.